Welcome to our dedicated page for Nakamoto SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kindly MD, Inc. (NAKA) SEC filings page provides access to the company’s official regulatory disclosures as a publicly traded issuer. KindlyMD, a patient-first and healthcare data company with integrated healthcare services and a Bitcoin treasury strategy via its subsidiary Nakamoto Holdings Inc., uses filings with the U.S. Securities and Exchange Commission to report material events, corporate actions, and financial information.
Among the key documents available are Current Reports on Form 8-K, which the company uses to disclose significant developments. Recent 8-K filings have addressed topics such as the completion of the merger with Nakamoto, entry into and termination of material loan agreements secured by Bitcoin or other digital assets, authorization of a share repurchase program, receipt of a Nasdaq minimum bid price notice, and the establishment of dates and record dates for annual shareholder meetings. These filings also cover matters like redemption of a secured convertible debenture and the company’s financing arrangements with lenders focused on digital assets.
Investors can also review proxy materials, including the Definitive Proxy Statement on Schedule 14A, which outlines proposals submitted to stockholders, such as the election of directors, approval of converting Kindly MD from a Utah corporation to a Delaware corporation, ratification of the independent registered public accounting firm, and potential adjournment of the annual meeting. Notifications of late filing on Form 12b-25 (NT 10-Q) provide context when additional time is needed to complete quarterly reports, including explanations related to the accounting complexity of the merger with Nakamoto.
On Stock Titan, these filings are complemented by AI-powered tools that help summarize lengthy documents and highlight key points, such as new financing obligations, changes in capital structure, or updates on the company’s Bitcoin treasury strategy. Users can quickly locate information about quarterly and annual reporting, material agreements, shareholder votes, and listing status, as well as track how KindlyMD’s integrated healthcare operations and Bitcoin-focused activities are reflected in its regulatory record.
Kindly MD, Inc. (NAKA) director Charles Phillip Blackburn filed an Initial Statement of Beneficial Ownership (Form 3) reporting no securities beneficially owned as of the event date 08/14/2025. The filing lists Blackburn's address in Salt Lake City and indicates the form was signed on 08/21/2025. The document includes an Exhibit 24 power of attorney reference.
The filing reports that Andrew Creighton, serving as Chief Compliance Officer and a director of Kindly MD, Inc. (ticker: NAKA), executed a transaction on 08/14/2025 acquiring 2,232,114 shares of the issuer's common stock at a reported price of $0. Following the reported acquisition, Mr. Creighton beneficially owns 3,124,971 shares. The Form 4 was signed by Mr. Creighton on 08/19/2025. No derivative securities were reported on this form and no additional explanatory text about the nature of the $0 price was provided in the filing.
Kindly MD, Inc. (NAKA) reporting person Andrew Creighton disclosed direct beneficial ownership of 892,857 shares of common stock on a Form 3 filed for the 08/14/2025 event. The filing identifies Mr. Creighton as a director and as Chief Compliance Officer and is signed 08/19/2025. The Form 3 documents initial ownership and includes Exhibit 24 (Power of Attorney).
David F. Bailey, who is listed as both Chief Executive Officer and a Director of Kindly MD, Inc. (NAKA), reported a transaction dated 08/14/2025 on Form 4. The filing shows an acquisition of 11,160,572 shares of Common Stock at a reported price of $0. Following the transaction, Mr. Bailey is reported to beneficially own 11,160,572 shares in a direct ownership form. The Form 4 is signed by Mr. Bailey on 08/15/2025.
Kindly MD, Inc. filed a Form 25 to remove its tradeable warrants to purchase shares of common stock (Nasdaq: NAKAW) from listing on The Nasdaq Stock Market LLC. This action relates specifically to the warrant class, not the underlying common stock, and is a formal step in ending exchange trading and/or registration of these warrants under Section 12(b) of the Securities Exchange Act of 1934.
Kindly MD, Inc. (NAKA) amended its corporate authorizations and conduct rules. The company increased authorized capital from 110,000,000 shares to 10,010,000,000 total shares, consisting of 10,000,000,000 shares of common stock (par value $0.001) and 10,000,000 shares of preferred stock (par value $0.001).
The company also expanded its Code to expressly cover consultants and contractors in addition to directors, officers, and employees, broadening who is bound by the company’s conduct rules. An exhibit list is referenced but not fully shown in the provided content.
Mark W. Yusko, a director of Kindly MD, Inc. (NAKA), reports direct beneficial ownership of 2,100,000 shares of the company's common stock. The filing is an initial disclosure of ownership under Section 16, showing the director holds the shares directly rather than through an indirect vehicle. The statement documents ownership but does not disclose any derivative holdings or changes in compensation or transactions.
Kindly MD, Inc. (NAKA) initial Form 3 discloses that Gregory Xethalis filed an insider statement as a director and reported no securities beneficially owned in the issuer. The filing lists a business address and indicates the form was filed by one reporting person. An exhibit references a Power of Attorney. The document is an initial statement of beneficial ownership and contains no entries in the non-derivative or derivative tables, indicating the reporting person holds no direct or indirect equity positions reported on this form.
Kindly MD, Inc. (NAKA) Form 3 filed by Amanda Fabiano reports her relationship to the issuer as a Director and Chief Operating Officer and is dated 08/14/2025. The filing states no securities are beneficially owned by the reporting person and includes an Exhibit 24 - Power of Attorney. The form is an initial statement of beneficial ownership and is signed by Amanda Fabiano.
Perianne Boring submitted an initial Form 3 for Kindly MD, Inc. (ticker NAKA) dated 08/14/2025. Ms. Boring is reported as a Director and the filing states she does not beneficially own any securities of the issuer. The form is signed by the reporting person and references an Exhibit 24 (Power of Attorney). No non-derivative or derivative holdings are listed.